Serial Number:
97822932
Mark:
GLYGENTRO
Status:
Notice of Allowance-Issued
Status Date:
01-23-2024
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations and substances for the treatment of metabolic and rare metabolic and genetic diseases and disorders; gene therapy products for the treatment of metabolic and rare diseases and disorders, namely, virus vector-based gene therapies for intravenous delivery Providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of metabolic and rare metabolic and genetic diseases and disorders Pharmaceutical, scientific, and medical research and development in the field of gene therapy manufacturing technology; biomedical and scientific research in the fields of gene therapy, and metabolic and rare metabolic and genetic diseases and disorders; biomedical research in the field of gene therapy design and delivery; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; scientific research in the nature of conducting clinical trials for others in the field of gene therapy design and delivery; pharmaceutical, scientific, and medical research, namely, compiling and sharing of patient data for research purposes in the field of metabolic and rare metabolic and genetic diseases and disorders; providing medical and scientific research information in the field of metabolic and rare metabolic and genetic diseases and disorders
Mark Description:
N/A
Class:
Medical services
Type of Mark:
Trademark
Published for Opposition Date:
11-28-2023
Mark Drawing Status:
Standart Character Mark
Abandon Date:
N/A
Business Name:
COOLEY LLP
Correspondent Name:
